drug eluting coronary stent

DEVICE4 trials

Sponsors

Cook Group Incorporated, Universita di Verona, Frisch Medical Device Private Limited

Conditions

AtherosclerosisCoronary Arterial Disease (CAD)Coronary Artery DiseaseIschemic Heart Disease

Phase 2

Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis

CompletedNCT00369356

Universita di VeronaAtherosclerosis, Coronary Artery Disease, Ischemic Heart Disease

Start: 2006-10-31End: 2011-01-31Updated: 2013-01-23

Phase 4

Clinical Investigation for Everolimus Drug Eluting Stent

CompletedNCT06769217

Frisch Medical Device Private LimitedCoronary Arterial Disease (CAD)

Start: 2023-01-01End: 2025-01-30Updated: 2026-03-11

Unknown Phase

In Stent ELUTES Study

CompletedNCT00225680

Cook Group IncorporatedCoronary Artery Disease

Start: 2002-04-30End: 2005-08-31Target: 124Updated: 2012-02-01

V-Flex Plus PTX Drug Eluting Coronary Stent

CompletedNCT00225693

Cook Group IncorporatedCoronary Artery Disease

Start: 2003-10-31End: 2005-07-31Target: 150Updated: 2012-02-01